HTG Molecular Diagnostics, Inc.
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:John_Lubniewski
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
drug development
biomarker discovery clinical diagnostics |
| gptkbp:foundedYear |
1997
|
| gptkbp:headquartersLocation |
gptkb:Tucson,_Arizona,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
HTG Molecular Diagnostics, Inc.
|
| gptkbp:industry |
molecular diagnostics
|
| gptkbp:product |
gptkb:HTG_EdgeSeq_Oncology_Biomarker_Panel
gptkb:HTG_EdgeSeq_miRNA_Whole_Transcriptome_Assay gptkb:HTG_EdgeSeq_technology |
| gptkbp:specializesIn |
precision medicine
RNA-based diagnostic technology |
| gptkbp:stockSymbol |
gptkb:HTGM
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.htgmolecular.com/
|
| gptkbp:bfsParent |
gptkb:HTG
|
| gptkbp:bfsLayer |
5
|